S
Shukra Pharmaceuticals Ltd
BSE:524632
Shukra Pharmaceuticals Ltd
BSE:524632
Price:
34.05
INR
-4.43%
Market Closed
Market Cap:
₹14.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Shukra Pharmaceuticals Ltd
BSE:524632
|
IN |
|
K
|
Kleannara Co Ltd
KRX:004540
|
KR |
|
Mid Penn Bancorp Inc
NASDAQ:MPB
|
US |
|
E
|
EMC PCL
SET:EMC
|
TH |
|
W
|
WEG SA
OTC:WEGZY
|
BR |
|
Playfair Mining Ltd
XTSX:PLY
|
CA |
Relative Value
The Relative Value of one SHUKRAPHAR stock under the Base Case scenario is hidden INR. Compared to the current market price of 34.05 INR, Shukra Pharmaceuticals Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
SHUKRAPHAR Relative Value
HIDDEN
Multiples Across Competitors
SHUKRAPHAR Competitors Multiples
Shukra Pharmaceuticals Ltd Competitors
Shukra Pharmaceuticals Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
S
|
Shukra Pharmaceuticals Ltd
BSE:524632
|
14.9B INR | 23.4 | 51.1 | 42 | 46.3 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
853.2B USD | 13.2 | 41.8 | 28.2 | 30.1 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.5B USD | 6.1 | 21.5 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.4B CHF | 4 | 18.9 | 11.2 | 12.6 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
288B USD | 4.5 | 16.1 | 10 | 12.2 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.2B GBP | 5 | 28.5 | 15.8 | 22.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
225.4B CHF | 5.2 | 21.1 | 13.1 | 16.8 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.4 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.3B USD | 2.5 | 20 | 7.7 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
115.5B USD | 2.5 | 16.8 | 7.1 | 8.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
